(SCMP) (SCMP) Stock Price, News & Analysis

Company Overview

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Its product candidates include VTS-270, Lubiprostone (AMITIZA), Unoprostone is opropyl (RESCULA) and CPP-1X/sulindac combination product. VTS-270 is an investigational drug under clinical study for the treatment of Niemann-Pick Disease Type C-1, an ultra-orphan, progressive and fatal disease. AMITIZA is a ClC-2 chloride channel activator, which has been approved for three indications that cover distinct patient types: chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. RESCULA is a Big Potassium channel activator used to lower intraocular pressure. CPP-1X/sulindac combination product is meant for the treatment of familial adenomatous polyposis (FAP).

Key Stats

• Today's Range: $18.00 to $18.00
• 50-Day Range: $18.00 to $18.00
• 52-Week Range: $9.30 to $18.75
• Volume: 303,068 shs
• Average Volume: 2.56 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SCMP Stock Analysis - Frequently Asked Questions

How were (SCMP)'s earnings last quarter?

(SCMP) (NASDAQ:SCMP) announced its quarterly earnings results on Wednesday, November, 1st. The biopharmaceutical company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. The company's quarterly revenue was up 5.9% compared to the same quarter last year.

What other stocks do shareholders of (SCMP) own?

Based on aggregate information from My MarketBeat watchlists, some other companies that (SCMP) investors own include XOMA Royalty (XOMA), Sprint (SPRINT), Micron Technology (MU), SandRidge Energy (SD), AT&T (T), Vale (VALE) and Cisco Systems (CSCO).

Company Calendar

• Last Earnings: 11/01/2017
• Today: 7/12/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:SCMP
• CIK: 1365216
• Web: www.sucampo.com
• Phone: +1-301-9613400
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A